Delivery Order SPE2DB22D1202-SPE2DB24FUKD6
Award Date 12/12/23
Potential Completion Date 12/13/23
Potential Value $3.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation operating through its Corporate Office division, has been awarded a firm fixed-price delivery order against an indefinite delivery contract held with the Defense Logistics Agency (DLA). The $2,209.94 order calls for the delivery of ketorolac tromethamine injection to DLA Troop Support Medical by December 15, 2023 to support pharmaceutical needs at military treatment facilities. Performance will take place at...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $1,581 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 60 mg/2 ml vials of ketorolac. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 2023. As a prime contractor, Amerisourcebergen Drug Corp routinely provides pharmaceuticals and medical supplies to DLA Troop Support Medical...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $1,125, this order is for the supply of 30 mg/ml vials of ketorolac to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 8, 2023. No set-aside designation was applied to this order. As a prime...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical in the amount of $2,249.76. The delivery order is for the supply of ketorolac 30 mg/ml vials to support DLA medical facilities and programs. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies to be delivered by November 1, 2023. No set-aside designation...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,872.52 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply ketorolac 15 mg/ml vials. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 4, 2023. As a prime contractor supporting DLA medical supply programs, Amerisourcebergen routinely provides pharmaceuticals and medical...
- Amerisourcebergen Drug Corp has received a $1,765.12 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply Ketorolac 30mg/ml 25s by December 14, 2023. The delivery order was awarded against an indefinite delivery contract held by Amerisourcebergen Drug Corp with no set-aside designation used. Performance will occur at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. As a leading pharmaceutical distributor, Amerisourcebergen Drug Corp...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $94,860 delivery order by the Defense Logistics Agency to provide 60 milligram/2 milliliter vials of ketorolac injectable medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract spanning September 8 through 11, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency utilizes...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $1,071.12, this order is for the supply of 4563250105 Ketorolac 30 mg/ml vials to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 1, 2023. No set-aside designation was applied to this award. As a...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $503,830 delivery order by the Defense Logistics Agency to provide ketorolac injection vials. The firm fixed price order is for the delivery of 4561680489 units of ketorolac 30 mg/ml vials to a location in Conshohocken, Pennsylvania and has a period of performance from August 2nd to August 3rd, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,259.96 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply ketorolac 15 mg/ml vials. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with all supplies delivered by November 30, 2023. No set-aside designation was applied to this order, which was awarded against an existing indefinite delivery contract held by...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUKD6Delivery Order
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical to provide $3,898.76 worth of ketorolac injection vials. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with completion by December 13, 2023. As a prime contractor and leading pharmaceutical distributor, Amerisourcebergen supports DLA's provision of medications and medical supplies to various military treatment programs. No set-aside designation was applied to this order to supply the nonsteroidal anti-inflammatory drug ketorolac for DLA medical facilities.
Generated 3/12/24, 10:48 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 12/12/23 |